REBLOZYL® (luspatercept-aamt) is a prescription medicine used to treat anemia (low red blood cells) in adults with beta thalassemia who need regular red blood cell (RBC) transfusions.
REBLOZYL is not for use as a substitute for RBC transfusions in people who need immediate treatment for anemia.
It is not known if REBLOZYL is safe or effective in children.
This website is best viewed using the horizontal display on your tablet device.
This website is best viewed using the vertical display on your mobile device.
Choosing a treatment to manage the symptoms of your anemia is a joint decision between you, your caregiver(s), and your healthcare team. If you have transfusion-dependent beta (β) thalassemia (BT) and anemia, REBLOZYL may be a treatment option for you.
When thinking about prescribing REBLOZYL, your healthcare team will also consider factors, such as:
Your current treatments
If you have any other health conditions, such as high blood pressure, or have had previous blood clots or extramedullary hematopoietic (EMH) masses
Considering these factors will help your doctor determine if REBLOZYL is right for you.
Every medicine comes with certain benefits and important safety considerations. These might include:
Having open conversations with your healthcare team is crucial to managing your treatment. Doing this from the start will set a strong foundation that will continue over time.
Come to appointments prepared with any information you’ve been keeping track of. This information can include recent blood transfusions, recent hemoglobin (Hgb) levels, and any new or changing symptoms
Talk openly about how treatment is going